###begin article-title 0
Persistent Hyperdopaminergia Decreases the Peak Frequency of Hippocampal Theta Oscillations during Quiet Waking and REM Sleep
###end article-title 0
###begin p 1
Conceived and designed the experiments: KD MALN. Performed the experiments: KD LS MALN. Analyzed the data: KD JS MALN. Contributed reagents/materials/analysis tools: RRG MGC MALN. Wrote the paper: KD SR RRG MGC MALN.
###end p 1
###begin p 2
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
Long-term changes in dopaminergic signaling are thought to underlie the pathophysiology of a number of psychiatric disorders. Several conditions are associated with cognitive deficits such as disturbances in attention processes and learning and memory, suggesting that persistent changes in dopaminergic signaling may alter neural mechanisms underlying these processes. Dopamine transporter knockout (DAT-KO) mice exhibit a persistent five-fold increase in extracellular dopamine levels. Here, we demonstrate that DAT-KO mice display lower hippocampal theta oscillation frequencies during baseline periods of waking and rapid-eye movement sleep. These altered theta oscillations are not reversed via treatment with the antidopaminergic agent haloperidol. Thus, we propose that persistent hyperdopaminergia, together with secondary alterations in other neuromodulatory systems, results in lower frequency activity in neural systems responsible for various cognitive processes.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 154 157 154 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-TimoIaria1">[1]</xref>
###xml 159 162 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Buzsaki1">[2]</xref>
###xml 273 276 273 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-TimoIaria1">[1]</xref>
###xml 277 280 277 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Jouvet1">[3]</xref>
###xml 398 401 398 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Siapas1">[4]</xref>
###xml 402 405 402 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Shin1">[6]</xref>
###xml 718 721 718 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Teitelbaum1">[7]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Kudina1">[10]</xref>
###xml 923 927 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Jucaite1">[11]</xref>
###xml 928 932 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Svenningsson1">[15]</xref>
###xml 1059 1063 1059 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gordon1">[16]</xref>
Hippocampal theta oscillations (HTO) are prominent local field potential oscillations generated by the brain, and occur within the 4-9 Hz frequency range [1], [2]. These oscillations are especially prominent during periods of exploration and rapid-eye-movement (REM) sleep [1]-[3], and play a critical role in high-end cognitive processes such as spatial learning, fear conditioning, and attention [4]-[6]. Many studies have been aimed at elucidating the neuromodulatory systems responsible for the generation and modulation of HTO's; however, the central methodologies employed across these studies have classically focused on using pharmacologic agents to acutely manipulate signaling within neuromodulatory systems [7]-[10]. Given the growing body of evidence suggesting that persistent changes in neuromodulatory systems underlie the behavioral and cognitive deficits observed across several neuropsychiatric disorders [11]-[15], there is increased demand for understanding how persistent changes in neuromodulatory systems alter these brain oscillations [16].
###end p 4
###begin p 5
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Lu1">[17]</xref>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Dzirasa1">[19]</xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Yamamoto1">[20]</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gainetdinov1">[21]</xref>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Jucaite1">[11]</xref>
###xml 709 713 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Laruelle1">[12]</xref>
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Horschitz1">[13]</xref>
###xml 290 294 <span type="species:ncbi:10116">rats</span>
The neurotransmitter dopamine (DA) is critically involved in regulating neural processes responsible for complex movements, emotions, attention, and arousal and sleep states [17]-[19]. Acute administration of psychostimulants or direct DA receptor agonists generate high frequency HTO's in rats [20]. Importantly, these agents modulate extracellular dopamine levels [21]. Despite the clear effects of acute hyperdopaminergia on HTO's, influences of persistent hyperdopaminergia on HTO's are obscure. This is an important omission given that long-term changes in DA signaling are thought to underlie, at least in part, the pathophysiology of attention-deficit-hyperactivity disorder (ADHD) [11], schizophrenia [12] and bipolar disorder [13].
###end p 5
###begin p 6
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gainetdinov1">[21]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Giros1">[22]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Pogorelov1">[25]</xref>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
DA transporter (DAT) knockout (KO) mice lack the gene encoding the plasma membrane transporter that regulates spatial and temporal DA signaling at the synapse. Due to loss of the DAT, these mutants exhibit a persistent 5-fold increase in extracellular DA levels [21], and show locomotor hyperactivity, deficits in sensorimotor gating, and impaired learning and memory [22]-[25]. Here we demonstrate that DAT-KO mice display significantly lower HTO frequencies during baseline waking and REM sleep periods. Additionally, we show that the altered HTO's observed in DAT-KO mice are not corrected via treatment with haloperidol. Thus, we propose that persistent hyperdopaminergia and its associated secondary changes in other neuromodulatory systems ultimately results in lower frequency activity in neural systems responsible for high-end cognitive processes.
###end p 6
###begin title 7
Materials and Methods
###end title 7
###begin title 8
Animals
###end title 8
###begin p 9
###xml 282 292 282 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 144 148 <span type="species:ncbi:10090">Mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
The WT and DAT-KO littermates were generated from heterozygotes that had been backcrossed over twenty generations onto the C57BL/6J background. Mice were housed three-five/cage and maintained in a humidity- and temperature-controlled room with standard lab chow and water available ad libitum. Thirteen male WT mice and eleven DAT-KO mice were separated into individual cages, and surgically implanted with electrodes and electromyographic (EMG) wires. Recording experiments were conducted following a one week recovery. All studies were conducted with approved protocols from the Duke University Institutional Animal Care and Use Committee and were in accordance with the NIH guidelines for the Care and Use of Laboratory Animals.
###end p 9
###begin title 10
Surgery
###end title 10
###begin p 11
###xml 6 10 <span type="species:ncbi:10090">mice</span>
Adult mice (20-35 weeks) were anesthetized with a Ketamine (100 mg/kg)/Xylazine (10 mg/kg) solution, placed in a stereotaxic device, and ground screws were secured to the cranium. Tungsten microwire array electrodes were implanted through a small cranial window into the dorsal hippocampus (stereotaxic coordinates: -2.3 mm anterior posterior, 1.6 mm mediolateral and 1.8 mm dorsoventral from bregma), and anchored to ground screws using dental acrylic. Tungsten EMG wires were placed into the trapezius muscle, and the skin was closed using surgical sutures.
###end p 11
###begin title 12
Experimental set-up for electrophysiological recordings
###end title 12
###begin p 13
All experiments were conducted in a recording chamber, consisting of an empty cage bottom (11.5 inx7 inx4.5 in) marked into six equal sections. Gross locomotor activity was determined by the number of section crosses normalized to total wake time during the recording period.
###end p 13
###begin title 14
Data acquisition
###end title 14
###begin p 15
Local field potentials (LFPs) were preamplified (500x), filtered (0.3-400 Hz), and digitized at 500 Hz using a Digital Acquisition card (National Instruments, Austin, TX) and a Multi-Neuron Acquisition Processor (Plexon, Dallas, TX). Behaviors were recorded with a video cassette recorder. Video images were loaded onto a cassette recorder and synchronized with the neural recordings using a millisecond-precision timer.
###end p 15
###begin title 16
Behavioral state and total theta power identification
###end title 16
###begin p 17
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Dzirasa1">[19]</xref>
###xml 1188 1191 1188 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Buzsaki1">[2]</xref>
###xml 2069 2075 2069 2075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9/0.15</italic>
###xml 2084 2090 2084 2090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9/0.11</italic>
###xml 2123 2143 2123 2143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">novel cage/home cage</italic>
###xml 2392 2396 2392 2396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Dzirasa1">[19]</xref>
###xml 1240 1244 <span type="species:ncbi:10090">mice</span>
###xml 1599 1603 <span type="species:ncbi:10090">mice</span>
###xml 2161 2165 <span type="species:ncbi:10090">mice</span>
###xml 2283 2287 <span type="species:ncbi:10090">mice</span>
Behavioral states were identified by combining two-dimensional state map and EMG cluster analysis as previously described [19]. Briefly, the state map generated cluster separation based on the high amplitude theta (4-9 Hz) and gamma (33-55 Hz) oscillations characteristic of REM sleep, the absence of gamma oscillations and the high amplitude delta (1-4 Hz) characteristic of SWS, and the high amplitude gamma oscillations and theta oscillations characteristic of waking. Minor scoring errors typically occurred in differentiating REM sleep from active exploration, thus EMG analysis was used to identify periods of atonia consistent with REM sleep, and combined with the two-dimensional state map cluster scoring method for all sleep experiments conducted in this study. LFP's were simultaneously recorded from 8 implanted electrodes, and the LFP which produced the best cluster separation was used for all experiments presented here. Importantly, our method did not control for the layer of hippocampus in which the recording electrode used for analysis was located. This is an important confound because the amplitude of theta oscillations change as a function of depth in hippocampus [2]. For instance, our experiments in which five WT mice were recorded in the novel environment, habituated environment, and during REM sleep reveal a high coefficient of variance (CV) in the maximum theta power measured across animals (CV = 0.49, 0.52, and 0.52, for recordings in the novel environment, habituated environment, and during REM sleep, respectively). Additionally, our experiments in five DAT-KO mice reveal a similarly high coefficient of variation (CV) in the maximum theta power measured across animals (CV = 0.56, 0.49, and 0.55, for recordings in the novel environment, habituated environment, and during REM sleep, respectively). However, we found that by normalizing the maximum mean theta power measured during the waking periods by that recorded during REM sleep for each animals, we were able to reduce the CV measured across animals by up to 80% (CV = 0.09/0.15, and 0.09/0.11 for theta power measured in the novel cage/home cage in WT and DAT-KO mice, respectively). Importantly, the mean power spectrum observed during REM sleep remained unchanged when DAT-KO and WT mice were treated with drugs, as well as during 12-hour experimental recordings conducted in their home cage [19]. These results indicate that the peak theta power observed during REM sleep can be utilized effectively as the baseline variable to correct for changes in theta wave amplitude recorded from different depths of hippocampus.
###end p 17
###begin title 18
Determination of peak theta frequency
###end title 18
###begin p 19
###xml 996 999 996 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Buzsaki1">[2]</xref>
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
First, all data segments with amplitude saturation were discarded from the dataset (2% of the total data per mouse). Using Matlab (MathWorks, Natick, MA), a sliding window Fourier transform was applied to the LFP signal using a 2 sec window with a 1 sec step. The Fourier transform parameters were chosen to allow for a frequency resolution of 0.5 Hz. Subsequently, LFP power spectra were then averaged across each period of interest (at least 2 total minutes for REM sleep, 10 total minutes for baseline waking, and 10 total minutes for active exploration), and the frequency at which the maximum spectral power occurred in the theta frequency (4-9 Hz) range was identified. For experiments examining REM sleep, we also determined the peak theta frequency using Fourier transform parameters chosen to allow for a frequency resolution of 0.25 Hz. The instantaneous phase values of theta oscillations shift throughout the depth of hippocampus; however, oscillations are phase locked across layers [2]. Thus, unlike measurements of theta power, the peak theta frequency is independent of which layer the recording electrode is located.
###end p 19
###begin title 20
Drug treatments during electrophysiological measurements
###end title 20
###begin p 21
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Dzirasa1">[19]</xref>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Jones1">[26]</xref>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
A 0.3 mg/kg (i.p.) dose of haloperidol (HAL) was chosen because it attenuates behavioral hyperactivity in novelty-exposed DAT-KO animals to a degree similar to that observed in untreated habituated WT mice [19]. d-Amphetamine (AMPH) was given at 3.0 mg/kg (i.p.) because it increased extracellular DA levels and induced behavioral hyperactivity in WT mice to similar degrees as those observed in untreated DAT-KO mice [26]. The serotonin selective reuptake inhibitor Fluoxetine (FLU) was given at 20 mg/kg (i.p.).
###end p 21
###begin title 22
Statistics
###end title 22
###begin p 23
###xml 376 377 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The data are presented as means and standard errors of the mean. The electrophysiological data were analyzed by two-way ANOVA, followed by Newman-Keuls (alpha = 0.05) tests for comparisons within genotype, and Student t-test for comparisons between genotypes. The behavioral data were analyzed by two-way ANOVA, followed by Student t-test for single comparisons. In all cases p<0.05 was considered significant.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
###xml 18 22 <span type="species:ncbi:10090">mice</span>
Hyperdopaminergic mice show alterations in baseline hippocampal theta oscillations
###end title 25
###begin p 26
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Dzirasa1">[19]</xref>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gainetdinov3">[24]</xref>
###xml 598 605 594 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g001">Fig. 1A</xref>
###xml 610 612 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g002">2E</xref>
###xml 762 769 754 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g001">Fig. 1A</xref>
###xml 1923 1926 1911 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Kichigina1">[9]</xref>
###xml 1928 1932 1916 1920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Yamamoto1">[20]</xref>
###xml 1934 1938 1922 1926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Nakagawa1">[27]</xref>
###xml 2301 2308 2285 2292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g001">Fig. 1B</xref>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 842 846 <span type="species:ncbi:10090">mice</span>
###xml 1289 1293 <span type="species:ncbi:10090">mice</span>
###xml 1367 1371 <span type="species:ncbi:10090">mice</span>
###xml 1428 1432 <span type="species:ncbi:10090">mice</span>
###xml 1520 1524 <span type="species:ncbi:10090">mice</span>
###xml 1547 1551 <span type="species:ncbi:10090">mice</span>
###xml 1660 1664 <span type="species:ncbi:10090">mice</span>
###xml 2058 2062 <span type="species:ncbi:10090">mice</span>
###xml 2127 2131 <span type="species:ncbi:10090">mice</span>
###xml 2183 2187 <span type="species:ncbi:10090">mice</span>
###xml 2228 2232 <span type="species:ncbi:10090">mice</span>
###xml 2254 2258 <span type="species:ncbi:10090">mice</span>
###xml 2281 2285 <span type="species:ncbi:10090">mice</span>
###xml 2543 2547 <span type="species:ncbi:10090">mice</span>
DAT-KO mice display a period of marked behavioral hyperactivity lasting up to four hours after introduction to a novel environment [19], [24]. Thus, in order to examine the effects of persistent hyperdopaminergia on baseline HTOs, DAT-KO and WT mice were habituated to the recording chamber for eight hours and subsequently subjected to two-hour continuous electrophysiological and behavioral recordings. Despite WT and DAT-KO mice showing similar behavioral profiles, total delta power (normalized delta power: WT mice: 3.6+/-0.5, DAT-KO mice: 4.3+/-0.4; n = 5; p>0.05) and total theta power (see Fig. 1A and 2E), DAT-KO mice displayed lower peak HTO frequencies during the baseline waking period than WT mice (WT mice: 7.1+/-0.2 Hz, DAT-KO mice: 5.7+/-0.2 Hz; Fig. 1A,). In order to ensure that the lower HTO frequencies observed in DAT-KO mice were truly due to changes associated with persistent hyperdopaminergia, and not simply behavioral differences that were too small to measure with our scoring technique, we implored a second behavioral scoring method based on our video data and EMG recordings. Using this method for five animals in each group, we identified the minimal EMG activity associated with movement and limited our analysis to include only one second intervals where mice displayed EMG activity below the movement threshold. Importantly, DAT-KO mice continued to display lower peak HTO frequencies than WT mice when the analysis was restricted to periods when both groups were completely still (WT mice: 6.9+/-0.3 Hz, DAT-KO mice: 5.7+/-0.4 Hz; n = 5 per group). Thus, the lower HTO frequencies observed in behaviorally habituated DAT-KO mice were indeed due to changes associated with persistent hyperdopaminergia and not simply small differences in behavioral profiles. This result was particularly interesting because acute treatments with DA agonists has been shown to induce high frequency HTO's [9], [20], [27]. Next, we investigated if these changes in HTO's were present across all baseline behavioral states observed in DAT-KO mice by analyzing HTO spectral patters observed across DAT-KO and WT mice during REM sleep. Our results indicate that DAT-KO mice show lower peak HTO frequencies than WT mice during REM sleep (WT mice: 7.2+/-0.1 Hz, DAT-KO mice: 6.5+/-0.2 Hz; Fig. 1B). Importantly, similar results were also obtained when the frequency resolution was increased from 0.5 Hz to 0.25 Hz. This demonstrates that lower frequency HTO's are present across both baseline waking and sleeping periods in DAT-KO mice.
###end p 26
###begin title 27
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Altered HTOs in hyperdopaminergic mice.
###end title 27
###begin p 28
###xml 303 307 303 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,49</sub>
###xml 341 345 341 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4,49</sub>
###xml 415 419 415 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4,49</sub>
###xml 877 884 877 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g002">Fig. 2F</xref>
###xml 990 994 990 994 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4,24</sub>
###xml 1026 1030 1026 1030 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4,24</sub>
###xml 1165 1167 1165 1167 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 1183 1185 1183 1185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 1412 1416 1412 1416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,39</sub>
###xml 1450 1454 1450 1454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3,39</sub>
###xml 1524 1528 1524 1528 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3,39</sub>
###xml 1564 1572 1564 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Post-hoc</italic>
###xml 1869 1873 1869 1873 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3,19</sub>
###xml 1908 1912 1908 1912 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3,19</sub>
###xml 2020 2022 2020 2022 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
###xml 931 935 <span type="species:ncbi:10090">mice</span>
###xml 1019 1023 <span type="species:ncbi:10090">mice</span>
###xml 1651 1655 <span type="species:ncbi:10090">mice</span>
###xml 1746 1750 <span type="species:ncbi:10090">mice</span>
###xml 1759 1763 <span type="species:ncbi:10090">mice</span>
###xml 1901 1905 <span type="species:ncbi:10090">mice</span>
Mean hippocampal LFP power distributions were calculated in the 2-12 Hz range for each mouse across the behavioral periods of interest. The images depict normalized power spectral distributions averaged across animals within genotype. Two way ANOVA of HTO frequency found the main effects of genotype [F1,49 = 21.66, p<0.01] and condition [F4,49 = 82.82, p<0.01], as well as the genotype by condition interaction [F4,49 = 9.96, p<0.01] to be significant. Post-hoc tests revealed that DAT-KO mice display lower hippocampal theta oscillation (HTO) frequencies than WT mice during (A) baseline waking (p<0.01) and (B) REM sleep periods (p = 0.011), but not (C) waking periods immediately following novelty exposure (p = 0.35). Locomotor activity measured during the A) habituated and C) novelty exposed waking states are depicted in insets, and behavioral statistics are shown in Fig. 2F. One way ANOVA found significant effects when mice were exposed to a novel environment for both DAT-KO [F4,24 = 54.47, p<0.01] and WT mice [F4,24 = 31.19, p<0.001]. Newman-Keuls tests showed that peak HTO frequencies increased with novelty exposure for both genotypes (DAT-KO: N-K20 = 3.92, WT: N-K20 = 2.35). Error bars represent S.E.M for normalized theta power determined for each frequency across animals within a genotype; n = 11 for both genotypes. Two way ANOVA of total theta power found the main effects of genotype [F1,39 = 15.21, p<0.01] and condition [F3,39 = 4.55, p<0.01], as well as the genotype by wake-state interaction [F3,39 = 6.46, p<0.01] to be significant. Post-hoc tests revealed that total theta power was not different between DAT-KO and WT mice during the baseline waking period (p>0.1); however, it was significantly higher in DAT-KO mice than WT mice following novelty exposure (p<0.01). One way ANOVA's found significant effects of condition for DAT-KO [F3,19 = 8.22, p<0.01] but not WT mice [F3,19 = 2.05, p>0.05]. Newman-Keuls tests showed that novelty exposure increased total theta power in DAT-KO (N-K10 = 4.66).
###end p 28
###begin title 29
###xml 70 74 <span type="species:ncbi:10090">mice</span>
The effect of psychoactive agents on HTO frequencies in WT and DAT-KO mice.
###end title 29
###begin p 30
###xml 379 381 379 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 409 411 409 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 551 553 551 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 581 583 581 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 757 759 757 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 776 778 776 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 917 919 917 919 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 940 942 940 942 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 1118 1121 1118 1121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,8</sub>
###xml 1212 1215 1212 1215 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,8</sub>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
###xml 1201 1205 <span type="species:ncbi:10090">mice</span>
###xml 1264 1268 <span type="species:ncbi:10090">mice</span>
###xml 1368 1372 <span type="species:ncbi:10090">mice</span>
###xml 1415 1419 <span type="species:ncbi:10090">mice</span>
Hippocampal LFP power distributions were calculated in the 2-12 Hz range for each mouse across the drug treatment of interest. The images depict normalized power spectral distributions averaged across animals within genotype and drug treatment. Treatment with haloperidol 0.3 mg/kg (HAL) significantly attenuated novelty induced peak HTO frequencies increases in both (A) WT (N-K20 = 3.39) and (B) DAT-KO (N-K20 = 3.29) mice, and treatment with d-amphetamine 3.0 mg/kg (AMPH) attenuated novelty induced peak HTO frequency increases in both (C) WT (N-K20 = 3.06) and (D) DAT-KO (N-K20 = 4.42) mice. (E) Novelty and psychoactive drug effects on total theta power. Treatment with AMPH, but not HAL, potentiated novelty-induced theta power in WT mice (AMPH: N-K20 = 5.01, HAL: N-K20 = 5.01). Novelty-induced theta power was attenuated by treatment with AMPH, and unaffected by treatment with HAL in DAT-KO mice (AMPH: N-K20 = 5.66, and HAL: N-K20 = 4.66, respectively). (F) Novelty and psychoactive drug effects on locomotor activity. WT and DAT-KO mice displayed similar behavioral profiles during baseline periods (tstat1,8 = 0.96, p = 0.36). Novelty exposure induced behavioral hyperactivity in DAT-KO mice (tstat1,8 = 2.39, p<0.05), compared to novelty exposed WT mice. HAL attenuated locomotor activity in both genotypes. AMPH attenuated locomotor activity in DAT-KO mice, and potentiated locomotor activity in WT mice. Error bars represent S.E.M for recordings within a genotype. # = p<0.05; compared to animals within genotype during the baseline period. * = p<0.05; compared to animals within genotype during the novelty exposed; n = 5 for all groups.
###end p 30
###begin p 31
###xml 560 567 556 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g001">Fig. 1C</xref>
###xml 783 790 779 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g001">Fig. 1C</xref>
###xml 796 803 792 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g002">Fig. 2E</xref>
###xml 894 898 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gainetdinov3">[24]</xref>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 889 893 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1153 1157 <span type="species:ncbi:10090">mice</span>
In order to determine if persistent hyperdopaminergia altered HTO activity during waking periods characterized by increased exploratory behavior, we conducted two-hour electrophysiological and behavioral recordings in DAT-KO and WT mice that were not habituated to the recording chamber. Interestingly, despite the marked behavioral hyperactivity displayed by the DAT-KO mice following exposure to the novel recording chamber, peak HTO frequencies were comparable to those observed in novelty-exposed WT mice (WT mice: 8.0+/-0.1 Hz, DAT-KO mice: 8.0+/-0.1 Hz, Fig. 1C). Peak HTO frequencies were, however, higher in novelty exposed WT and DAT-KO mice than those observed during the baseline waking period. Novelty exposure also increased theta power in DAT-KO mice, but not WT mice (Fig. 1C, see Fig. 2E). Importantly, exposure to novelty does not change dopaminergic tone in WT or DAT-KO mice [24]. Therefore, as WT and DAT-KO mice display similar peak HTO frequencies following exposure to novelty, while dopaminergic tone remains constant, our results suggest that persistent hyperdopaminergia does not decrease the peak frequency of HTO's in DAT-KO mice across all behavioral states.
###end p 31
###begin p 32
###xml 398 402 <span type="species:ncbi:10090">mice</span>
Overall, our findings suggest that persistent hyperdopaminergia generates compensatory network changes which decrease the peak frequency of HTO's during baseline behavioral periods. Conversely, our results also raise the possibility that hyperdopaminergia lowers peak HTO frequencies across all behavioral states, and that the similar peak HTO frequencies observed in novelty exposed WT and DAT-KO mice is a result of the higher behavioral profiles exhibited by DAT-KO animals.
###end p 32
###begin title 33
Acute Dopamine D2 receptor transmission involved in novelty-induced increases in HTO frequencies
###end title 33
###begin p 34
###xml 338 345 338 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g002">Fig. 2F</xref>
###xml 450 457 446 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g002">Fig. 2A</xref>
###xml 518 525 510 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g002">Fig. 2B</xref>
###xml 817 824 809 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g002">Fig. 2E</xref>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
Next, we investigated the molecular mechanisms underlying the changes in HTO's observed in DAT-KO mice. DAT-KO mice and WT mice were treated with the D2 dopamine receptor antagonist haloperidol 0.3 mg/kg, i.p. (HAL), and two-hour electrophysiological and behavioral recordings were conducted. HAL attenuated behavioral hyperactivity (see Fig. 2F) and novelty-induced peak HTO frequency increases in both WT (vehicle: 8.0+/-0.1 Hz, HAL: 6.5+/-0.2 Hz; Fig. 2A) and DAT-KO mice (vehicle: 8.0+/-0.1 Hz, HAL: 6.3+/-0.1 Hz; Fig. 2B). Taken together, these findings demonstrate that acute dopaminergic transmission, via the D2 dopamine receptor, plays a critical role in the induction of high frequency HTO's in DAT-KO mice following novelty exposure. Interestingly, HAL did not reduce total theta power in DAT-KO mice (see Fig. 2E), suggesting that alterations in other neuromodulatory systems may mediate the novelty induced increases in theta power observed in these animals.
###end p 34
###begin p 35
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Zetler1">[28]</xref>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 931 935 <span type="species:ncbi:10090">mice</span>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
Next, we investigated the effect of HAL on the altered HTO's observed during baseline behavioral periods in DAT-KO mice. Systemic administration of pharmacological agents induced behavioral hyperactivity in habituated DAT-KO mice, thus we employed a modified experimental paradigm. Firstly, behavioral and electrophysiological recordings were extended to four hours in WT and DAT-KO mice treated with HAL. Secondly, analysis was limited to periods of REM sleep occurring within this four hour window. Because the four hour recording period was within the half-life of HAL in mice [28], and the effect of external behavioral influences on HTO's is relatively limited during REM sleep, this experimental paradigm allowed us quantify the effect of HAL on the altered HTO frequencies observed in habituated DAT-KO mice. Our results showed that DAT-KO mice treated with HAL displayed lower peak HTO frequencies during REM sleep that WT mice treated with HAL (WT mice: 7.5+/-0.3 Hz, DAT-KO mice: 6.6+/-0.1 Hz, p<0.02). These results indicate that HAL does not attenuate the altered HTO frequencies observed in DAT-KO mice during baseline behavioral periods.
###end p 35
###begin title 36
DA independent modulation of HTOs
###end title 36
###begin p 37
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Yamamoto1">[20]</xref>
###xml 502 505 500 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,8</sub>
###xml 526 533 524 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g002">Fig. 2C</xref>
###xml 604 611 602 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g002">Fig. 2E</xref>
###xml 788 792 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gainetdinov2">[23]</xref>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
Next, we conducted our recording protocol in WT mice treated with the psychostimulant d-amphetamine 3.0 mg/kg, i.p. (AMPH). Dopamine agonists have been shown to increase peak HTO frequencies [20]; thus, we predicted that treatment with AMPT would increase peak HTO frequencies in WT animals. Surprisingly, our results showed that WT mice treated with d-amphetamine displayed peak HTO frequencies that were significantly lower than those observed in WT mice treated with vehicle (WT: 6.7+/-0.1 Hz; tstat1,8 = 3.9, p<0.005, see Fig. 2C). We also found that AMPH increased total theta power in WT mice (see Fig. 2E). While AMPH causes a profound increase in dopamine release in WT animals at the dose used for this experiment (3.0 mg/kg), it has also been shown to increase serotonin levels [23]. Thus, we set out to investigate if the lower peak HTO frequencies observed in WT mice treated with AMPH resulted from acute hyperdopaminergia or secondary changes in other neuromodulatory systems.
###end p 37
###begin p 38
###xml 277 280 275 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,8</sub>
###xml 493 497 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gainetdinov1">[21]</xref>
###xml 569 573 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gainetdinov2">[23]</xref>
###xml 575 579 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gainetdinov3">[24]</xref>
###xml 689 696 683 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g002">Fig. 2D</xref>
###xml 874 876 868 870 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 1028 1031 1018 1021 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,8</sub>
###xml 1196 1203 1186 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005238-g002">Fig. 2E</xref>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
###xml 956 960 <span type="species:ncbi:10090">mice</span>
###xml 1186 1190 <span type="species:ncbi:10090">mice</span>
###xml 1402 1406 <span type="species:ncbi:10090">mice</span>
###xml 1411 1415 <span type="species:ncbi:10090">mice</span>
###xml 1441 1445 <span type="species:ncbi:10090">mice</span>
Firstly, WT animals were treated with both HAL and AMPH, and electrophysiological data was collected during the 2-hour recording period. Our results showed that AMPH significantly lowered peak HTO frequencies in WT animals treated with HAL (WT/HAL and AMPH: 5.9+/-0.2 Hz; tstat1,8 = 2.9, p<0.02), indicting that HAL did not attenuate the peak HTO frequency lowering effect of AMPH. Secondly, we treated DAT-KO mice with d-amphetamine. DAT-KO mice lack a key target of AMPH, the DA transporter [21], and thus the drug exerts a calming effect via serotonergic mechanisms [23], [24]. In DAT-KO mice, AMPH significantly lowered peak HTO frequencies (vehicle: 8.0+/-0.1 Hz, AMPH: 5.3+/-0.4 Hz; Fig. 2D). Upon further analysis, we also found that DAT-KO mice treated with AMPH displayed peak HTO frequencies that were even lower than those observed in DAT-KO treated with HAL (N-K10 = 4.00). Incidentally, AMPH attenuated novelty-induced hyperactivity in DAT-KO mice to a lesser degree than HAL (HAL: 0.4+/-0.1, AMPH: 1.7+/-0.3, tstat1,8 = 3.9, p<0.005). Moreover, in contrast to HAL, treatment with AMPH also significantly attenuated novelty induced increases in total theta power in DAT-KO mice (see Fig. 2E). Finally, we treated WT animals with the serotonin selective reuptake inhibitor fluoxetine (FLU, 20 mg/kg i.p.). Our results showed that FLU significantly lowered the peak frequency of HTO's in WT mice (WT mice/Saline: 8.0+/-0.1 Hz, WT mice/FLU: 6.6+/-0.3 Hz, n = 5, p<0.05), suggesting that increases in serotonergic tone were sufficient to reduced HTO frequencies.
###end p 38
###begin p 39
Taken together, these results suggest that the lower peak HTO frequencies observed in WT animals treated with AMPH are likely due to secondary changes in serotonergic neuromodulatory systems, and not acute hyperdopaminergia.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 298 301 298 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Kichigina1">[9]</xref>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Yamamoto1">[20]</xref>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Nakagawa1">[27]</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Our findings demonstrate that DAT-KO mice display decreased hippocampal theta oscillations frequencies during baseline waking periods and REM sleep. Incidentally, these findings are in contrast to studies that have shown that acute treatment with DA agonists generates increases in HTO frequencies [9], [20], [27]. Thus, our findings reveal for the first time that persistent hyperdopaminergia lowers baseline hippocampal theta oscillation frequencies.
###end p 41
###begin p 42
###xml 215 218 215 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-TimoIaria1">[1]</xref>
###xml 220 223 220 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Buzsaki1">[2]</xref>
###xml 380 383 380 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Siapas1">[4]</xref>
###xml 385 388 385 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Seidenbecher1">[5]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Bragin1">[29]</xref>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Fries1">[30]</xref>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Wespatat1">[31]</xref>
###xml 879 883 879 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Santos1">[32]</xref>
HTO's are prominent LFP's generated by the brain, and occur in the 4-9 Hz frequency range. These oscillations are especially prominent during waking periods of increased attention and rapid-eye-movement (REM) sleep [1], [2]. HTO's control the timing of activity across neuronal populations in hippocampus, prefrontal cortex, and amygdala and coordinate gamma oscillatory activity [4], [5], [29]. Gamma oscillations are a major indicator of cortical processing and a critical determinant of long term potentiation and depression [30], [31]. Thus, even small changes in baseline HTO frequencies are likely to alter neural activity across large distributed brain networks, ultimately generating deficits in gross behavioral processes. Importantly, baseline HTO frequencies observed during quiet waking and REM sleep have been shown to be predictive of learning rates across rodents [32].
###end p 42
###begin p 43
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Vanderwolf2">[33]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Dzirasa1">[19]</xref>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
###xml 854 858 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
###xml 1089 1093 <span type="species:ncbi:10090">mice</span>
###xml 1246 1250 <span type="species:ncbi:10090">mice</span>
###xml 1565 1569 <span type="species:ncbi:10090">mice</span>
HTO's are also highly correlated with behaviors such as changes in posture or limb position, walking, head movements, and rearing [33]. We have previously shown that the enhanced theta power observed in DAT-KO mice following novelty exposure is not simply due to the increased locomotor activity observed in these animals [19]. While peak HTO frequencies increase in WT and DAT-KO mice following novelty-induced hyperactivity as well, the changes in baseline HTO's observed in DAT-KO mice are unlikely to be due to gross locomotor behavioral changes. Firstly, despite demonstrating similar behavioral profiles during the baseline waking period, DAT-KO mice display significantly lower the peak frequency of HTO's. Importantly, this difference persists even when our analysis is restricted to intervals when animals are completely still. Moreover, DAT-KO mice display lower peak HTO frequencies than WT mice during periods of REM sleep where both genotypes of mice are behaviorally inactive. WT and DAT-KO also display similar peak HTO frequencies following novelty exposure, though DAT-KO mice experience a significant increase in gross locomotor activity. Collectively, these findings suggest that the altered HTO frequencies observed in DAT-KO mice HTO's can be dissociated from changes in gross locomotor behavioral activity. Secondly, though treatment with AMPH induces gross locomotor hyperactivity in WT animals, it lowered peak theta oscillations frequencies. Moreover, treatment with d-amphetamine caused greater decreases in peak HTO frequencies in DAT-KO mice than treatment with haloperidol, though haloperidol attenuated behavioral hyperactivity to a greater degree. Taken together, these findings provide compelling evidence that persistent hyperdopaminergia generates changes in HTO's that are locomotor activity independent, resulting in a decrease in the peak frequency of HTO's during baseline periods.
###end p 43
###begin p 44
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Carlsson1">[18]</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Kellendonk1">[34]</xref>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Breitenstein1">[35]</xref>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
DA is critically involved in regulating neural processes responsible for complex movements and emotions [18]. Consequently, altered central dopaminergic neurotransmission has been implicated in several neurological and psychiatric disorders such as schizophrenia, Parkinson's disease, and ADHD. While recent evidence demonstrates that transient over-expression of striatal D2 dopamine receptors during development results in deficits in working memory [34], and that increases in tonic dopaminergic stimulation generate global deficits in learning and memory [35], it is unclear how persistent changes in dopaminergic transmission alter neural activity in brain areas that mediate cognitive processes. Our results demonstrate that persistent hyperdopaminergia generates a baseline slowing of hippocampal neural networks. Additionally, we show that while administration of the classic antidopaminergic agent HAL attenuates behavioral hyperactivity in DAT-KO mice, it does not correct the reduced peak HTO frequencies observed during baseline behavioral periods.
###end p 44
###begin p 45
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gainetdinov1">[21]</xref>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gainetdinov2">[23]</xref>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gainetdinov3">[24]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Staub1">[36]</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Gordon1">[16]</xref>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
Moreover, we show that treatment with AMPH attenuates novelty-induced behavioral hyperactivity, and reduces the peak frequency of HTO's and HTO power in persistently hyperdopaminergic mutants. DAT-KO mice lack a key target of AMPH, the DA transporter [21]; thus, it is likely that AMPH exerts a calming effect via serotonergic mechanisms [23], [24]. Recent evidence has shown that the stress cascade modulates central serotonergic signaling [36], and that disruption of serotonergic signaling mechanisms increase HTO power [16].
###end p 45
###begin p 46
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Pogorelov1">[25]</xref>
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005238-Wu1">[37]</xref>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
Taken together with our findings, this suggests that the baseline HTO alterations observed in DAT-KO mice may be mediated via changes in the serotonergic neuromodulatory system, and that the behavioral hyperactivity, and peak theta frequency and power increases observed in novelty exposed DAT-KO mice are likely mediated in-part by stress induced disruption of serotonergic mechanisms. Indeed, DAT-KO mice display profound alterations in serotonin homeostasis that may underlie the changes in baseline neuron-oscillatory properties presented here [25]. Thus, we propose that persistent hyperdopaminergia induces compensatory changes in serotonergic systems, in order to regulate information flow through circuits responsible for locomotor behavior [37], which result in slower processing rates in hippocampal neural networks. Overall, the present results show that DAT-KO mice display decreased HTO frequencies, and demonstrate the central role of persistent hyperdopaminergia in modulating baseline hippocampal neural oscillatory activity.
###end p 46
###begin p 47
We would like to thank G. Lehew and Jim Meloy for technical assistance; L. Oliveira, T. Jones, and G. Wood for miscellaneous support; and S. Halkiotis for proofreading of this manuscript. We would also like to thank Rui M. Costa, Shih-Chieh Lin, Ramona M. Rodriguiz, and William C. Wetsel for helpful comments on this manuscript. A special thanks to Freeman Hrabowski, Robert and Jane Meyerhoff, and the Meyerhoff Scholarship Program.
###end p 47
###begin title 48
References
###end title 48
###begin article-title 49
###xml 34 37 <span type="species:ncbi:10116">rat</span>
Phases and states of sleep in the rat.
###end article-title 49
###begin article-title 50
Theta oscillations in the hippocampus.
###end article-title 50
###begin article-title 51
Biogenic amines and the states of sleep.
###end article-title 51
###begin article-title 52
Prefrontal phase locking to hippocampal theta oscillations.
###end article-title 52
###begin article-title 53
Amygdalar and hippocampal theta rhythm synchronization during fear memory retrieval.
###end article-title 53
###begin article-title 54
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Genetic dissection of theta rhythm heterogeneity in mice.
###end article-title 54
###begin article-title 55
Behaviorally evoked hippocampal theta waves: a cholinergic response.
###end article-title 55
###begin article-title 56
Hippocampal electrical activity during waking behaviour and sleep: analyses using centrally acting drugs.
###end article-title 56
###begin article-title 57
###xml 82 88 <span type="species:ncbi:9986">rabbit</span>
Dopaminergic regulation of theta activity of septohippocampal neuron in the awake rabbit.
###end article-title 57
###begin article-title 58
###xml 109 115 <span type="species:ncbi:9986">rabbit</span>
The serotonin reuptake inhibitor fluoxetine suppresses theta oscillations in the electroencephalogram of the rabbit hippocampus.
###end article-title 58
###begin article-title 59
Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
###end article-title 59
###begin article-title 60
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.
###end article-title 60
###begin article-title 61
A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression.
###end article-title 61
###begin article-title 62
Reduced serotonin type 1A receptor binding in panic disorder.
###end article-title 62
###begin article-title 63
Alterations in 5-HT1B receptor function by p11 in depression-like states.
###end article-title 63
###begin article-title 64
###xml 91 95 <span type="species:ncbi:10090">mice</span>
State-dependent alterations in hippocampal oscillations in serotonin 1A receptor-deficient mice.
###end article-title 64
###begin article-title 65
Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter.
###end article-title 65
###begin article-title 66
Perspectives on the discovery of central monoaminergic neurotransmission.
###end article-title 66
###begin article-title 67
Dopaminergic Control of Sleep-Wake States.
###end article-title 67
###begin article-title 68
Cortical and hippocampal EEG power spectra in animal models of schizophrenia produced with methamphetamine, cocaine, and phencyclidine.
###end article-title 68
###begin article-title 69
Monoamine transporters: from genes to behavior.
###end article-title 69
###begin article-title 70
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
###end article-title 70
###begin article-title 71
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter.
###end article-title 71
###begin article-title 72
Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
###end article-title 72
###begin article-title 73
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene.
###end article-title 73
###begin article-title 74
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.
###end article-title 74
###begin article-title 75
###xml 102 106 <span type="species:ncbi:10116">rats</span>
Effect of dopaminergic drugs on the reserpine-induced lowering of hippocampal theta wave frequency in rats.
###end article-title 75
###begin article-title 76
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Pharmacokinetics and effects of haloperidol in the isolated mouse.
###end article-title 76
###begin article-title 77
###xml 65 68 <span type="species:ncbi:10116">rat</span>
Gamma (40-100 Hz) oscillation in the hippocampus of the behaving rat.
###end article-title 77
###begin article-title 78
The gamma cycle.
###end article-title 78
###begin article-title 79
###xml 68 71 <span type="species:ncbi:10116">rat</span>
Phase sensitivity of synaptic modifications in oscillating cells of rat visual cortex.
###end article-title 79
###begin article-title 80
Baseline hippocampal theta oscillation speeds correlate with rate of operant task acquisition.
###end article-title 80
###begin article-title 81
Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior.
###end article-title 81
###begin article-title 82
Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.
###end article-title 82
###begin article-title 83
Tonic dopaminergic stimulation impairs associative learning in healthy subjects.
###end article-title 83
###begin article-title 84
Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
###end article-title 84
###begin article-title 85
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice.
###end article-title 85
###begin p 86
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 86
###begin p 87
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by funding from the Duke Medical Scientist Training Program, Wakeman Foundation, Ruth K. Broad Foundation, and UNCF/Merck to KD; from Pew Latin American Fellowship to SR; from NARSAD and NIH to MGC; and from the International Neuroscience Network Foundation (INNF), NIH/NINDS R33NS049534, NARSAD, and HDF to MALN. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke (NINDS) or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 87

